Dr Jenna Carpenter explains her research project exploring a gene therapy for Dravet Syndrome 

Dr Jenna Carpenter’s project aims to develop a groundbreaking gene therapy for Dravet Syndrome and has been co-funded as a fellowship by Dravet Syndrome UK and the Epilepsy Research Institute. This innovative therapy would offer a permanent treatment, uniquely designed to adapt dynamically to the patient's developing brain over their lifetime. Beyond stopping seizures, this on-demand therapy could significantly alleviate other debilitating aspects of the condition. By integrating cutting-edge technologies into their research, the team are setting a new standard in treatments for Dravet Syndrome and other rare genetic epilepsies.